Publications

5674 Results

Preliminary toxicity results from Southwest Oncology Group trial (SWOG) 9705: A phase II trial of cisplatin, etoposide and paclitaxel (PET) with G-CSF in untreated patients (PTS) with extensive small cell lung cancer (SCLC).

Authors
PA Bunn;K Kelly;J Crowley;RB Livingston;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 18:468a(#1807)
Year
1999
Research Committee(s)
Lung
Study Number(s)
S9705

A randomized phase III trial of paclitaxel plus carboplatin (PC) versus vinorelbine plus cisplatin (VC) in untreated advanced non-small cell lung cancer (NSCLC): A Southwest Oncology Group (SWOG) trial.

Authors
K Kelly;J Crowley;PA Bunn;RB Livingston;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 18:461a(#1777)
Year
1999
Research Committee(s)
Lung
Study Number(s)
SWOG-9509

Preliminary analysis of the E1690/S9111/C9190 intergroup postoperative adjuvant trial of high-and low- dose IFNa2b (HDI and LDI) in high-risk primary or lymph node metastatic melanoma.

Authors
JM Kirkwood;J Ibrahim;V Sondak;M Ernstoff;L Flaherty;T Smith;J Richards;U Rao;M Steele;R Blum
Journal / Conference
Proc of the American Society of Clinical Oncology 18:537a(#2072)
Year
1999
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9111 (EST-1690)

E2690: Intergroup immunological evaluation of IFNa2b dose-response in patients (Pts) with high-risk melanoma.

Authors
H Zarour;T Richards;T Whiteside;J Sosman;J Ibrahim;M Ernstoff;R Blum;JM Kirkwood
Journal / Conference
Proc of the American Society of Clinical Oncology 18:538a(#2079)
Year
1999
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9325 (EST-2690)

Effect of chemohormonal therapy in premenopausal, node (+), receptor (+) breast cancer: An Eastern Cooperative Oncology Group phase III intergroup trial (E5188, INT-0101).

Authors
N Davison;A O'Neill;T Habermann;CK Osborne;S Martino;D White;MD Abeloff
Journal / Conference
Proc of the American Society of Clinical Oncology 18:67a(#249)
Year
1999
Research Committee(s)
Breast
Study Number(s)
SWOG-8851 (INT-0101) (EST-5188)

Concordance of pre-and post- chemotherapy p53 immunostaining, and its prognostic significance in epithelial ovarian cancer (EOC) receiving intraperitoneal (IP) consolidation: A Southwest Oncology Group study (SWOG-9521).

Authors
L Pandit;PY Liu;FM Muggia;JC Felix;D Hawes;KY Terada;JC Paradelo;RJ Cote;DS Alberts
Journal / Conference
Proc of the American Society of Clinical Oncology 18:382a(#1475)
Year
1999
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9521

Prognostic significance of p53 and K-RAS mutations in primary resected non-small cell lung cancer: Preliminary results from a propsective randomized trial of postoperative adjuvant therapy (intergroup trial 0115).

Authors
JH Schiller;S Adak;R Feins;S Keller;W Fry;RB Livingston;B Wolf;J Jett;L Kohman;D Johnson;E Hammond
Journal / Conference
Proc of the American Society of Clinical Oncology 18:464a(#1789)
Year
1999
Research Committee(s)
Lung
Study Number(s)
SWOG-9323 (E4592)

Phase II trial of CI-980 in patients with disseminated malignant melanoma: A Southwest Oncology Group Study.

Authors
RP Whitehead;JM Unger;LE Flaherty;JR Eckardt;SA Taylor;MS Didolkar;W Samlowski;VK Sondak
Journal / Conference
Proc of the American Society of Clinical Oncology 18:554(#2138)
Year
1999
Research Committee(s)
Melanoma
Study Number(s)
S9622

A phase II trial of vinorelbine in relapsed and refractory ovarian cancer - A Southwest Oncology Group study (SWOG-9324).

Authors
ML Rothenberg;PY Liu;WA Nahhas;GR Weiss;LE Schroder;L Elias;S Wilczynski;G Winakur;DS Alberts
Journal / Conference
Proc of the American Society of Clinical Oncology 18:383a(#1480)
Year
1999
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9324

Cloning and chromosomal localization of the gene encoding human cyclin D-binding Myb-like protein (hDMP1).

Authors
SM Bodner;CW Naeve;KM Rakestraw;BG Jones;VA Valentine;MB Valentine;FW Luthardt;CL Willman;SC Raimondi;JR Downing;MF Roussel;CJ Sherr;AT Look
Journal / Conference
Gene 229:223-228
Year
1999
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9030, SWOG-9034 (EST-3489) (CALGB-9120)